Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #842
- Final score
- 30.17
- Years on list
- 6
↘ Down 270 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 270 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 183 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 170 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | JAZZ | BMRN | BRKR |
|---|---|---|---|
| Climate Change | 28.3 | 24.5 | 28.5 |
| Employee Relations | 37.5 | 38.6 | 18.1 |
| Environment | 18.8 | 26.8 | 25.6 |
| Stakeholders & Society | 41.1 | 25.1 | 21.9 |
| Human Rights | 18.3 | 28.8 | 34.3 |
| Governance | 31.1 | 36.3 | 27.8 |
| Performance Rating | 47.7 | 58.4 | 36.6 |